CELANESE CORP (CE) Stock Fundamental Analysis
USA - NYSE:CE - US1508701034 - Common Stock
44.25 USD
-1.23 (-2.7%)
44.25 USD
0 (0%)
CE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. CE has a bad profitability rating. Also its financial health evaluation is rather negative. CE is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CE was profitable.
CE had a positive operating cash flow in the past year.
Of the past 5 years CE 4 years were profitable.
In the past 5 years CE always reported a positive cash flow from operatings.
1.2 Ratios
CE has a worse Return On Assets (-6.83%) than 73.49% of its industry peers.
CE has a Return On Equity of -30.71%. This is in the lower half of the industry: CE underperforms 75.90% of its industry peers.
CE has a Return On Invested Capital of 3.49%. This is comparable to the rest of the industry: CE outperforms 45.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CE is in line with the industry average of 6.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.83% | ||
| ROE | -30.71% | ||
| ROIC | 3.49% |
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
1.3 Margins
The Operating Margin of CE (9.38%) is comparable to the rest of the industry.
CE's Operating Margin has declined in the last couple of years.
The Gross Margin of CE (21.85%) is worse than 60.24% of its industry peers.
In the last couple of years the Gross Margin of CE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.38% | ||
| PM (TTM) | N/A | ||
| GM | 21.85% |
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CE is destroying value.
The number of shares outstanding for CE has been increased compared to 1 year ago.
CE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CE is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.52, we must say that CE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.52, CE is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
The Debt to FCF ratio of CE is 20.48, which is on the high side as it means it would take CE, 20.48 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.48, CE perfoms like the industry average, outperforming 46.99% of the companies in the same industry.
A Debt/Equity ratio of 2.43 is on the high side and indicates that CE has dependencies on debt financing.
CE has a Debt to Equity ratio of 2.43. This is amonst the worse of the industry: CE underperforms 84.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.43 | ||
| Debt/FCF | 20.48 | ||
| Altman-Z | 1.52 |
ROIC/WACC0.48
WACC7.32%
2.3 Liquidity
A Current Ratio of 2.05 indicates that CE has no problem at all paying its short term obligations.
The Current ratio of CE (2.05) is comparable to the rest of the industry.
CE has a Quick Ratio of 1.22. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
CE has a Quick ratio (1.22) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
CE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.87%.
CE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.59% yearly.
The Revenue has decreased by -5.83% in the past year.
Measured over the past years, CE shows a quite strong growth in Revenue. The Revenue has been growing by 10.30% on average per year.
EPS 1Y (TTM)-35.87%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-39.5%
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-4.49%
3.2 Future
The Earnings Per Share is expected to grow by 5.09% on average over the next years.
CE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.51% yearly.
EPS Next Y-46.21%
EPS Next 2Y-14.08%
EPS Next 3Y-2.21%
EPS Next 5Y5.09%
Revenue Next Year-5.19%
Revenue Next 2Y-1.48%
Revenue Next 3Y0.26%
Revenue Next 5Y0.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.50, the valuation of CE can be described as very cheap.
Based on the Price/Earnings ratio, CE is valued cheaply inside the industry as 90.36% of the companies are valued more expensively.
CE is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.18, which indicates a rather cheap valuation of CE.
Based on the Price/Forward Earnings ratio, CE is valued cheaper than 92.77% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CE to the average of the S&P500 Index (22.86), we can say CE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.5 | ||
| Fwd PE | 7.18 |
4.2 Price Multiples
CE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CE is cheaper than 61.45% of the companies in the same industry.
CE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CE is cheaper than 92.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.67 | ||
| EV/EBITDA | 9.61 |
4.3 Compensation for Growth
CE's earnings are expected to decrease with -2.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.08%
EPS Next 3Y-2.21%
5. Dividend
5.1 Amount
CE has a yearly dividend return of 0.26%, which is pretty low.
Compared to an average industry Dividend Yield of 3.47, CE is paying slightly less dividend.
With a Dividend Yield of 0.26, CE pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.26% |
5.2 History
The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CE decreased recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
CE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-9.81%
EPS Next 2Y-14.08%
EPS Next 3Y-2.21%
44.25
-1.23 (-2.7%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners107.4%
Inst Owner Change5.36%
Ins Owners0.27%
Ins Owner Change2.52%
Market Cap4.85B
Analysts71.54
Price Target55.66 (25.79%)
Short Float %6.18%
Short Ratio3.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.26% |
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-9.81%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.13%
Min EPS beat(2)-0.14%
Max EPS beat(2)44.41%
EPS beat(4)2
Avg EPS beat(4)11.14%
Min EPS beat(4)-16.92%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.27%
EPS beat(12)5
Avg EPS beat(12)1.38%
EPS beat(16)7
Avg EPS beat(16)2.17%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)2.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.21%
Revenue beat(12)1
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-2.02%
PT rev (1m)-15.08%
PT rev (3m)-13.02%
EPS NQ rev (1m)-5.43%
EPS NQ rev (3m)-27.25%
EPS NY rev (1m)-0.4%
EPS NY rev (3m)-13.93%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.5 | ||
| Fwd PE | 7.18 | ||
| P/S | 0.49 | ||
| P/FCF | 7.67 | ||
| P/OCF | 4.75 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.61 |
EPS(TTM)5.9
EY13.33%
EPS(NY)6.16
Fwd EY13.93%
FCF(TTM)5.77
FCFY13.04%
OCF(TTM)9.32
OCFY21.05%
SpS90.77
BVpS48.18
TBVpS-36.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.83% | ||
| ROE | -30.71% | ||
| ROCE | 4.45% | ||
| ROIC | 3.49% | ||
| ROICexc | 3.7% | ||
| ROICexgc | 6.89% | ||
| OM | 9.38% | ||
| PM (TTM) | N/A | ||
| GM | 21.85% | ||
| FCFM | 6.36% |
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexcg growth 3Y-25.53%
ROICexcg growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.43 | ||
| Debt/FCF | 20.48 | ||
| Debt/EBITDA | 7.49 | ||
| Cap/Depr | 49.62% | ||
| Cap/Sales | 3.9% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 1.52 |
F-Score4
WACC7.32%
ROIC/WACC0.48
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.87%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-39.5%
EPS Next Y-46.21%
EPS Next 2Y-14.08%
EPS Next 3Y-2.21%
EPS Next 5Y5.09%
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-4.49%
Revenue Next Year-5.19%
Revenue Next 2Y-1.48%
Revenue Next 3Y0.26%
Revenue Next 5Y0.51%
EBIT growth 1Y-19.24%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.28%
EBIT Next 3Y12.65%
EBIT Next 5Y9.93%
FCF growth 1Y-41.64%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-39.07%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%